Evaluation of CD38 as target for immunotherapy in multiple myeloma

The multifactorial etiology of graft-versus-host disease.

Immunology today·2014

Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.

Clinical and experimental immunology·2010

Combined immersion and oral vaccination of Vietnamese catfish (Pangasianodon hypophthalmus) confers protection against mortality caused by Edwardsiella ictaluri.

Fish & shellfish immunology·2009

Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.

Anticancer research·2008

Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.

Journal of chemotherapy (Florence, Italy)·2006

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.

Cancer immunology, immunotherapy : CII·2005

T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

Blood·2026

Ferroptotic stress promotes hematopoietic stem cell aging through S1P-dependent epigenetic and lipid remodeling.

Blood·2026

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Blood·2026

Whole genome sequencing to elucidate novel genetic modifiers of FVIII clearance.

Blood·2026

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

Blood·2026

NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib.

Blood·2026

Understanding Mycobacterium tuberculosis host immune responses and identifying synergistic autophagy-inducing compounds as potential nanomedicines for tuberculosis treatment.

Nanomedicine (London, England)·2026

Tumor Budding Unveiled: Clinicopathological Correlations and Survival Insights From a Tertiary Care Cancer Center of India.

International journal of breast cancer·2026

Regulatory T cells in the bladder cancer tumor microenvironment: mechanisms of immune suppression and therapeutic opportunities.

Frontiers in molecular biosciences·2026

Case Report: Pulmonary fibroleiomyomatous hamartoma presenting as a giant exophytic multilocular cystic lesion.

Frontiers in medicine·2026

A locally deployed large language model for pathology-informed and nurse-reviewed communication support in bladder cancer immunotherapy.

Frontiers in medicine·2026

Inflammatory myofibroblastic tumor of the larynx: a case report.

Frontiers in oncology·2026

Related Experiment Videos

Evaluation of CD38 as target for immunotherapy in multiple myeloma

Related Concept Videos

The multifactorial etiology of graft-versus-host disease.

Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.

Combined immersion and oral vaccination of Vietnamese catfish (Pangasianodon hypophthalmus) confers protection against mortality caused by Edwardsiella ictaluri.

Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.

Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.

T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

Ferroptotic stress promotes hematopoietic stem cell aging through S1P-dependent epigenetic and lipid remodeling.

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Whole genome sequencing to elucidate novel genetic modifiers of FVIII clearance.

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib.

Understanding Mycobacterium tuberculosis host immune responses and identifying synergistic autophagy-inducing compounds as potential nanomedicines for tuberculosis treatment.

Tumor Budding Unveiled: Clinicopathological Correlations and Survival Insights From a Tertiary Care Cancer Center of India.

Regulatory T cells in the bladder cancer tumor microenvironment: mechanisms of immune suppression and therapeutic opportunities.

Case Report: Pulmonary fibroleiomyomatous hamartoma presenting as a giant exophytic multilocular cystic lesion.

A locally deployed large language model for pathology-informed and nurse-reviewed communication support in bladder cancer immunotherapy.

Inflammatory myofibroblastic tumor of the larynx: a case report.

Related Experiment Videos

Evaluation of CD38 as target for immunotherapy in multiple myeloma

Related Concept Videos

Related Articles